Gavi, the Vaccine Alliance (formerly The Global Alliance for Vaccines and Immunization), is a public–private global health partnership founded in 2000 to expand equitable access to immunization in low- and lower-middle-income countries. Headquartered in Geneva, Switzerland, it convenes national governments, the World Health Organization, UNICEF, the World Bank, the Bill & Melinda Gates Foundation, vaccine manufacturers, civil society, and research institutions.
Gavi finances vaccine procurement and delivery, supports health system strengthening, and shapes vaccine markets by aggregating demand, making long-term funding commitments (such as advance market commitments), and promoting price transparency, with procurement typically conducted through UNICEF. It has backed the introduction of vaccines including pneumococcal, rotavirus, HPV, malaria, and COVID-19, and co-led the COVAX Facility with WHO and CEPI during the pandemic. Funding is sourced from donor governments and private partners—using mechanisms such as the International Finance Facility for Immunisation (IFFIm)—alongside country co-financing and a pathway to transition to self-financing.
Also known as The Global Alliance for Vaccines and Immunization.
€75M quasi‑equity and $20M senior loan finance a South African end‑to‑end multi‑vaccine plant (2028) to produce cholera, polio, pneumonia and meningitis vaccines (30–40M doses/yr); 340 skilled, 7,000 indirect jobs.
